FPCP
MRK icon

Fort Point Capital Partners’s Merck MRK Stock Holding History

Fort Point Capital Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$837K Buy
6,908
+43
+0.6% +$4.96K 0.1% 107
2025
Q4 		$762K Buy
6,865
+880
+15% +$82.6K 0.09% 120
2025
Q3 		$507K Sell
5,985
-3,964
-40% -$326K 0.06% 144
2025
Q2 		$797K Sell
9,949
-505
-5% -$40.1K 0.06% 172
2025
Q1 		$938K Buy
10,454
+147
+1% +$13.7K 0.1% 132
2024
Q4 		$1.03M Buy
10,307
+1,116
+12% +$115K 0.11% 124
2024
Q3 		$1.04M Buy
9,191
+476
+5% +$56.6K 0.13% 106
2024
Q2 		$1.08M Sell
8,715
-265
-3% -$34.1K 0.14% 111
2024
Q1 		$1.18M Sell
8,980
-168
-2% -$20.7K 0.16% 104
2023
Q4 		$997K Buy
9,148
+150
+2% +$15.6K 0.14% 106
2023
Q3 		$926K Buy
8,998
+550
+7% +$59.3K 0.14% 96
2023
Q2 		$975K Sell
8,448
-886
-9% -$101K 0.14% 96
2023
Q1 		$993K Buy
9,334
+149
+2% +$16.1K 0.15% 104
2022
Q4 		$1.02M Hold
9,185
– – 0.16% 99
2022
Q3 		$791K Hold
9,185
– – 0.13% 114
2022
Q2 		$837K Sell
9,185
-10
-0.1% -$887 0.14% 110
2022
Q1 		$754K Buy
9,195
+1,902
+26% +$150K 0.11% 132
2021
Q4 		$559K Buy
7,293
+18
+0.2% +$1.43K 0.08% 150
2021
Q3 		$546K Buy
7,275
+630
+9% +$47.9K 0.08% 131
2021
Q2 		$517K Sell
6,645
-319
-5% -$23.7K 0.09% 94
2021
Q1 		$512K Buy
6,964
+1,258
+22% +$92.8K 0.11% 87
2020
Q4 		$445K Buy
5,706
+1,115
+24% +$85.3K 0.1% 94
2020
Q3 		$363K Sell
4,591
-479
-9% -$37.5K 0.09% 91
2020
Q2 		$374K Sell
5,070
-43
-0.8% -$3.24K 0.12% 87
2020
Q1 		$375K Buy
5,113
+276
+6% +$21.7K 0.16% 65
2019
Q4 		$420K Hold
4,837
– – 0.15% 82
2019
Q3 		$388K Buy
4,837
+2,299
+91% +$184K 0.15% 77
2019
Q2 		$203K Buy
+2,538
New +$194K 0.08% 98
2019
Q1 		– Sell
-4,020
Closed -$293K – 136
2018
Q4 		$293K Buy
4,020
+189
+5% +$13.3K 0.12% 113
2018
Q3 		$259K Buy
+3,831
New +$244K 0.08% 129
2018
Q2 		– Sell
-4,806
Closed -$250K – 147
2018
Q1 		$250K Sell
4,806
-1,179
-20% -$63.7K 0.09% 131
2017
Q4 		$325K Buy
5,985
+417
+7% +$23.1K 0.15% 88
2017
Q3 		$343K Buy
+5,568
New +$338K 0.16% 90
2016
Q4 		– Sell
-4,925
Closed -$283K – 135
2016
Q3 		$283K Buy
+4,925
New +$288K 0.13% 102
2015
Q4 		– Sell
-5,389
Closed -$254K – 116
2015
Q3 		$254K Sell
5,389
-623
-10% -$33.1K 0.16% 63
2015
Q2 		$327K Buy
6,012
+96
+2% +$5.38K 0.21% 49
2015
Q1 		$324K Buy
5,916
+1,043
+21% +$59.1K 0.21% 42
2014
Q4 		$264K Buy
+4,873
New +$271K 0.2% 43

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fort Point Capital Partners's MRK Position: Q1 2026 in Review

Fort Point Capital Partners increased its Merck (MRK) stake by 0.63% in Q1 2026, buying an estimated $4.96K and bringing the position to 6,908 shares worth $837K. The position accounts for 0.1% of the portfolio, ranked #107.

Fort Point Capital Partners first reported a position in MRK in Q4 2014 and has held it in 38 quarters since. The position peaked at $1.18M in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Fort Point Capital Partners held 6,908 shares of Merck worth $837K as of Q1 2026.
  • Fort Point Capital Partners bought 43 Merck shares in Q1 2026, an estimated $4.96K.
  • Merck made up 0.1% of Fort Point Capital Partners's portfolio in Q1 2026, its #107 holding.
  • Fort Point Capital Partners first reported a position in Merck in Q4 2014 and has held it in 38 quarters since.
  • Fort Point Capital Partners's Merck position peaked at $1.18M in Q1 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Fort Point Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.